These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29670052)

  • 1. Aneuploid CTC and CEC.
    Lin PP
    Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29670052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.
    Lin PP; Gires O; Wang DD; Li L; Wang H
    Sci Rep; 2017 Aug; 7(1):9789. PubMed ID: 28852197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells.
    Lin PP
    Clin Transl Med; 2015 Dec; 4(1):38. PubMed ID: 26718583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
    Ge F; Zhang H; Wang DD; Li L; Lin PP
    Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic monitoring of CD45-/CD31+/DAPI+ circulating endothelial cells aneuploid for chromosome 8 during neoadjuvant chemotherapy in locally advanced breast cancer.
    Ma G; Jiang Y; Liang M; Li J; Wang J; Mao X; Veeramootoo JS; Xia T; Liu X; Wang S
    Ther Adv Med Oncol; 2020; 12():1758835920918470. PubMed ID: 32489429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1
    Zhang L; Zhang X; Liu Y; Zhang T; Wang Z; Gu M; Li Y; Wang DD; Li W; Lin PP
    Cancer Lett; 2020 Jan; 469():355-366. PubMed ID: 31678168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Atlas of Circulating Rare Cells Detected by SE-iFISH and Image Scanning Platform in Patients With Various Diseases.
    Hu B; Gong Y; Wang Y; Xie J; Cheng J; Huang Q
    Front Oncol; 2022; 12():821454. PubMed ID: 35311070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantified postsurgical small cell size CTCs and EpCAM
    Wang L; Li Y; Xu J; Zhang A; Wang X; Tang R; Zhang X; Yin H; Liu M; Wang DD; Lin PP; Shen L; Dong J
    Cancer Lett; 2018 Jan; 412():99-107. PubMed ID: 29031565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H
    Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Comprehensive Co-Detection of Necrotic and Viable Aneuploid Cancer Cells in Peripheral Blood.
    Lin AY; Wang DD; Li L; Lin PP
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial cells in guidance of specifying the field cancerized surgical excision margin and administering immunotherapy.
    Fu Z; Zhang L; Chen R; Zhan J; Zhong J; Zheng W; Zou J; Wang P; Deng X; Lin AY; Wang DD; Lin PP; He R
    Cancer Lett; 2024 Aug; 598():217099. PubMed ID: 38971491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer.
    Cheng H; Wang S; Luan W; Ye X; Dou S; Tang Z; Zhu H; Lin PP; Li Y; Cui H; Chang X
    Chin J Cancer Res; 2021 Apr; 33(2):256-270. PubMed ID: 34158744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity.
    Yang X; Lv J; Zhou Z; Feng D; Zhou R; Yuan B; Wu Q; Yu H; Han J; Cao Q; Gu M; Li P; Yang H; Lu Q
    Front Oncol; 2021; 11():802188. PubMed ID: 35186716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
    Li M; Gao F; Ren X; Dong G; Chen H; Lin AY; Wang DD; Liu M; Lin PP; Shen S; Jiang H; Yang C; Zhang X; Zhao X; Zhu Q; Li M; Cui Y; Lin S
    Cancer Sci; 2022 Oct; 113(10):3535-3546. PubMed ID: 35940591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
    Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
    Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer.
    Lei Y; Sun N; Zhang G; Liu C; Lu Z; Huang J; Zhang C; Zang R; Che Y; Mao S; Fang L; Wang X; Zheng S; He J
    Clin Transl Med; 2020 Jul; 10(3):e128. PubMed ID: 32659050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
    Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking circulating PD-L1-positive cells to monitor the outcome of patients with gastric cancer receiving anti-HER2 plus anti-PD-1 therapy.
    Chong X; Li Y; Lu J; Feng X; Li Y; Zhang X
    Hum Cell; 2024 Jan; 37(1):258-270. PubMed ID: 37889437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.